Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations

Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations

Background: Clonal hematopoiesis of indeterminate potential (CHIP) is a novel cardiovascular disease (CVD) risk factor in individuals without acute myeloid leukemia (AML). Objectives: The aim of this study was to examine the association between mutations associated with CHIP (CHIP-related mutations)...

Full description

Bibliographic Details
Main Authors: Abdel-Qadir, H. (Author), Calvillo-Argüelles, O. (Author), Capo-Chichi, J.-M (Author), Carrillo-Estrada, M. (Author), Gupta, V. (Author), Liu, S. (Author), Natarajan, P. (Author), Schimmer, A.D (Author), Schoffel, A. (Author), Schuh, A. (Author), Shlush, L.I (Author), Thavendiranathan, P. (Author), Yee, K. (Author)
Format: Article
Language:English
Published: Elsevier Inc. 2022
Subjects:
acute coronary syndrome
acute myeloid leukemia
adult
age
aged
Article
ASXL1 gene
cardiovascular disease
cardiovascular diseases
cardiovascular mortality
cause of death
clonal hematopoiesis
clonal hematopoiesis of indeterminate potential
cohort analysis
coronary artery recanalization
DNMT3A gene
female
gene
gene mutation
heart failure
hospitalization
human
ischemic stroke
JAK2 gene
major clinical study
male
SF3B1 gene
SRSF2 gene
TET2 gene
TP53 gene
venous thromboembolism
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items